You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地發布最新國家組織藥品集中採購文件 按反內捲原則力保「降價不降質」
國家醫保局發布全國藥品集中採購文件,以規範化制度化常態化推進藥品集中帶量採購,進一步降低群眾用藥負擔。
據《央視》報道,此次集採方案制定和修改過程中,充分遵循「穩臨床、保質量、防圍標、反內捲」原則。關於「反內捲」集採秉持公開透明及公平公正的市場化競爭機制,企業自願參加及自主報價,同時旗幟鮮明地反對過度內捲。
文件中要求每家投標企業做出不低於成本報價的承諾,對於低於「錨點價」的企業,要求其對報價合理性作出聲明,解釋具體成本構成,包括製造成本、期間費用及銷售利潤等,主導回應社會對低價中選的顧慮。在「穩臨床」方面,保障臨床用藥需求是集採的基本目標,也是優化集采措施的重點。
此外,此次集採充分徵求並採納藥監部門及市場監管部門意見,在保證公平的基礎上,對投標企業的質控水平提出更高要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.